MilliporeSigma invests €130M to expand single-use manufacturing in Molsheim

MilliporeSigma, the Life Science business of Merck KGaA, is investing €130 million to expand manufacturing capacity for Mobius single-use assemblies at its Molsheim, France site, creating over 800 jobs by 2028.

“MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that the Life Science business strengthened its manufacturing capabilities for single-use assemblies... by investing € 130 million in Molsheim, France.”prnewswire.com

• 1 source
• prnewswire.comMilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, FranceMilliporeSigmaSep 8, 2022

Summarized from public sources; check the original articles before acting on it.